Fundz

Relevance Ventures has led a multi-million Series B financing for Aqua Medical to advance its innovative Type 2 diabetes treatment. This funding aims to enhance Aqua's novel endoscopic approach to the disease.

PRIVATESep 23, 2026

Round Type

Series B

CaliforniaBiotechnologyHealth CareMedicalMedical DeviceTherapeutics

Investors

Relevance Ventures

Description

Relevance Ventures announced it led a multimillion Series B financing round for Aqua Medical, a company focused on treating Type 2 diabetes. The announcement coincided with Relevance's participation as a sponsor at the 2026 NAFOA Fall Finance & Tribal Economies Conference. Aqua Medical is pursuing a unique approach to a disease that heavily impacts Native American communities. This investment reflects the commitment to addressing significant health challenges through innovative solutions.

Quick answer

Aqua Medical raised an undisclosed amount in a Series B round, dated September 23, 2026. Investors: Relevance Ventures. Aqua Medical is based in California, United States.

How much did Aqua Medical raise?
Aqua Medical raised an undisclosed amount in a Series B round on September 23, 2026.
Who invested in Aqua Medical?
Relevance Ventures is named as investors in this round.
What does Aqua Medical do?
Aqua Medical is developing minimally invasive endoscopic therapies for type 2 diabetes and Barrett’s Esophagus.
Where is Aqua Medical based and how big is it?
Aqua Medical is based in California, United States. Fundz records about 11 employees.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Aqua Medical that raised within 45 days of this round, from Fundz verified event records.

  • StimCardio raised $30M (Series A) on October 29, 2026.
  • Alethio raised $90M (Series A) on November 5, 2026.
  • Laza Medical raised $160M (Series B) on November 4, 2026.
  • Sonocare Lab raised an undisclosed amount (Seed) on October 29, 2026.
  • Impress raised $45M (Debt Financing) on October 27, 2026.
  • Tivic raised $85M (Series B) on October 27, 2026.

Who to call at Aqua Medical, and when

A new round usually means Aqua Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aqua Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aqua Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aqua Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aqua Medical

Location

California, United States

About

Aqua Medical is developing minimally invasive endoscopic therapies for type 2 diabetes and Barrett’s Esophagus. The company is focused on advancing a proprietary radiofrequency vapor ablation platform designed for outpatient settings. Aqua Medical aims to expand access to interventional metabolic therapies. The company is targeting a large market with significant unmet needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aqua Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Aqua Medical's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Aqua Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.